Geetashree Mukherjee
Overview
Explore the profile of Geetashree Mukherjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, Bhardwaj S, Ghorai S, Ahmed R, Agarwal S, Mukherjee G, et al.
J Liq Biopsy
. 2025 Mar;
7:100287.
PMID: 40027231
Background: Liquid biopsy-based biomarkers offer several advantages since they are minimally invasive, can be useful in longitudinal monitoring of the disease and have higher patient compliance. We describe a protocol...
2.
Shaikh S, Dhar H, Moorthy M, Bhat V, Basu S, Banerjee D, et al.
J Transl Med
. 2024 Aug;
22(1):759.
PMID: 39138492
Background: Oral cancer poses a significant health challenge due to limited treatment protocols and therapeutic targets. We aimed to investigate the invasive margins of gingivo-buccal oral squamous cell carcinoma (GB-OSCC)...
3.
Shaikh S, Basu S, Bag S, Chatterjee A, Datta S, Banerjee D, et al.
Sci Rep
. 2024 May;
14(1):11609.
PMID: 38773214
No biomarker has yet been identified that allows accurate diagnosis and prognosis of oral cancers. In this study, we investigated the presence of key metabolites in oral cancer using proton...
4.
Chatterjee A, Chaudhary A, Ghosh A, Arun P, Mukherjee G, Arun I, et al.
Cancer Med
. 2023 Jul;
12(16):16774-16787.
PMID: 37392167
Background: For various cancers, differences in response to treatment and subsequent survival period have been reported to be associated with variation in immune contextures. Aim: We sought to identify whether...
5.
Bag S, Oetjen J, Shaikh S, Chaudhary A, Arun P, Mukherjee G
Mol Cell Biochem
. 2023 Mar;
479(1):41-49.
PMID: 36966422
MALDI imaging for metabolites and immunohistochemistry for 38 immune markers was used to characterize the spatial biology of 2 primary oral tumours, one from a patient with an early recurrence...
6.
Dey D, Lali B, Roy P, Midha D, Arun I, Zameer L, et al.
Ecancermedicalscience
. 2022 Oct;
16:1441.
PMID: 36200017
A central review of histopathology specimens at tertiary oncology hospitals is important for optimum patient care in the modern era of personalised medicine. The challenges of healthcare delivery and access...
7.
Saha S, Ghosh P, Mukherjee G, Roy A
Indian J Radiol Imaging
. 2022 Aug;
32(2):270-274.
PMID: 35924124
Neuroendocrine tumors (NETs) occur more commonly in lungs, gastrointestinal tract, or pancreas. NETs in locations such as ovaries are rare, and they have been described mainly in case reports. Here...
8.
Nair M, D A, M C, Vp S, Patil S, Ce A, et al.
Cells
. 2022 May;
11(10).
PMID: 35626709
ER-positive (ER+) breast cancer is considered immunologically ‘silent’ with fewer tumor-infiltrating immune cells. We have previously demonstrated the role of miR-18a in mediating invasion and poor prognosis in ER+ breast...
9.
Karmakar T, Banerjee S, Brahma S, Dey D, Radhakrishnan V, Chandy M, et al.
Indian J Hematol Blood Transfus
. 2022 May;
38(2):403-410.
PMID: 35496962
Routine diagnostic biopsy tissue processing, conventional histology/immunohistochemistry (IHC) method is a multi-step and time consuming practice. With the advanced tissue dissociation protocols and panel designing, flow cytometric immunophenotyping (FCI) can...
10.
Chaudhary A, Bag S, Arora N, Radhakrishnan V, Mishra D, Mukherjee G
Front Oral Health
. 2022 Jan;
1:585710.
PMID: 35047983
Oral squamous cell carcinoma (OSCC) includes tumors of the lips, tongue, gingivobuccal complex, and floor of the mouth. Prognosis for OSCC is highly heterogeneous, with overall 5-year survival of ~50%,...